# Effects of n3 LC PUFAs on Inflammatory, Immune and Senescence Features in Polyvascular Older Subjects (OMSAGE)

> **NCT06666101** · NA · NOT_YET_RECRUITING · sponsor: **Université Libre de Bruxelles** · enrollment: 80 (estimated)

## Conditions studied

- Polyvascular Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Long chain polyunsaturated Omega-3
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06666101
- **Lead sponsor:** Université Libre de Bruxelles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-04
- **Primary completion:** 2025-11-04
- **Final completion:** 2025-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-10-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06666101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06666101, "Effects of n3 LC PUFAs on Inflammatory, Immune and Senescence Features in Polyvascular Older Subjects (OMSAGE)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06666101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*